Related references
Note: Only part of the references are listed.Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease
Maiko T. Uemura et al.
ACTA NEUROPATHOLOGICA (2022)
Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities
Robin de Flores et al.
JOURNAL OF NEUROSCIENCE (2022)
Structure of pathological TDP-43 filaments from ALS with FTLD
Diana Arseni et al.
NATURE (2022)
Limbic-Predominant Age-Related TDP-43 Encephalopathy Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis
Kathryn M. Gauthreaux et al.
NEUROLOGY (2022)
TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration
Marina Buciuc et al.
NEUROIMAGE-CLINICAL (2022)
White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
Sheelakumari Raghavan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)
Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases
Andrew Chang et al.
CELL (2022)
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
Alba Cervantes Gonzalez et al.
MOLECULAR NEURODEGENERATION (2022)
Age-dependent formation of TMEM106B amyloid filaments in human brains
Manuel Schweighauser et al.
NATURE (2022)
Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43
Yi Xiao Jiang et al.
NATURE (2022)
Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
Teresa Gomez-Isla et al.
NATURE REVIEWS NEUROLOGY (2022)
Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer's disease
Michael Tran Duong et al.
NATURE COMMUNICATIONS (2022)
Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
Peter T. Nelson et al.
ACTA NEUROPATHOLOGICA (2022)
Tau-Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease
Sandhitsu R. Das et al.
ANNALS OF NEUROLOGY (2021)
Blood TDP-43 Combined with Demographics Information Predicts Dementia Occurrence in Community Non-Dementia Elderly
Lin Sun et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis
Leon Beyer et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons
Sonal Agrawal et al.
BRAIN PATHOLOGY (2021)
TDP-43 Pathology in Alzheimer's Disease
Axel Meneses et al.
MOLECULAR NEURODEGENERATION (2021)
Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathology
Sadhana Ravikumar et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons
Sonal Agrawal et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo
Silvia Porta et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)
Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy
Michael Tran Duong et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease
Douglas P. Wightman et al.
NATURE GENETICS (2021)
What Is the Role of Stathmin-2 in Axonal Biology and Degeneration?
Eduardo Benarroch
NEUROLOGY (2021)
TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
Yuting Ren et al.
FRONTIERS IN NEUROLOGY (2021)
Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions
L. E. M. Wisse et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study
Adam J. Dugan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
The development and convergence of co-pathologies in Alzheimer's disease
John L. Robinson et al.
BRAIN (2021)
TDP-43 proteinopathies: a new wave of neurodegenerative diseases
Eva Maria Johanna de Boer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion
Zeran Li et al.
ACTA NEUROPATHOLOGICA (2020)
Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE): Clinical and Neuropathological Associations
Lilah M. Besser et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease
Robin de Flores et al.
ALZHEIMERS & DEMENTIA (2020)
TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression
Josiah J. Herzog et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Hippocampal sclerosis, TDP-43, and the duration of the symptoms of dementia of AD patients
Oscar L. Lopez et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration
John L. Robinson et al.
BRAIN (2020)
Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy
Marina Buciuc et al.
NEUROLOGY (2020)
Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging
Alifiya Kapasi et al.
NEUROLOGY (2020)
Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology
Hyun-Sik Yang et al.
NEURON (2020)
The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies
Myungjin Jo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
TDP-43 Is Elevated in Plasma Neuronal-Derived Exosomes of Patients With Alzheimer's Disease
Nan Zhang et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia
Mercedes Prudencio et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathology
David X. Thomas et al.
SCIENTIFIC REPORTS (2020)
TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer's disease
Yao-Hsiang Shih et al.
NATURE COMMUNICATIONS (2020)
Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease
Kathy Y. Liu et al.
BRAIN (2020)
RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43
Jacob R. Mann et al.
NEURON (2019)
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Peter T. Nelson et al.
BRAIN (2019)
Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults
Nazanin Makkinejad et al.
NEUROBIOLOGY OF AGING (2019)
Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease
Ece Bayram et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort
Caitlin S. Latimer et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair
Joseph R. Klim et al.
NATURE NEUROSCIENCE (2019)
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration
Ze'ev Melamed et al.
NATURE NEUROSCIENCE (2019)
Current radiotracers to image neurodegenerative diseases
Solveig Tiepolt et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis
Vivek Majumder et al.
BMC NEUROLOGY (2018)
FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis
Hugo Botha et al.
BRAIN (2018)
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
John L. Robinson et al.
BRAIN (2018)
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease
Sukriti Nag et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization
Leeanne McGurk et al.
MOLECULAR CELL (2018)
Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study
Hyun-Sik Yang et al.
LANCET NEUROLOGY (2018)
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2015
Paul Mehta et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and cerebrovascular disease pathologies
Yuriko Katsumata et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies
Lin Guo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Ageing as a risk factor for ALS/FTD
Teresa Niccoli et al.
HUMAN MOLECULAR GENETICS (2017)
Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study
Keith A. Josephs et al.
LANCET NEUROLOGY (2017)
TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss
Rosa C. Paolicelli et al.
NEURON (2017)
A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression
Michael D. Gallagher et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
ALS/FTLD: experimental models and reality
Rachel H. Tan et al.
ACTA NEUROPATHOLOGICA (2017)
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia
Bryan D. James et al.
BRAIN (2016)
The TMEM106B locus and TDP-43 pathology in older persons without FTLD
Lei Yu et al.
NEUROLOGY (2015)
TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies
Joery Goossens et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Staging TDP-43 pathology in Alzheimer's disease
Keith A. Josephs et al.
ACTA NEUROPATHOLOGICA (2014)
ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology
Peter T. Nelson et al.
ACTA NEUROPATHOLOGICA (2014)
The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function
Owen A. Brady et al.
HUMAN MOLECULAR GENETICS (2013)
TDP-43 Pathology, Cognitive Decline, and Dementia in Old Age
Robert S. Wilson et al.
JAMA NEUROLOGY (2013)
The epidemiology of frontotemporal dementia
Chiadi U. Onyike et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2013)
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
Julie van der Zee et al.
BRAIN (2011)
TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies
Todd J. Cohen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Cytoplasmic Mislocalization of TDP-43 Is Toxic to Neurons and Enhanced by a Mutation Associated with Familial Amyotrophic Lateral Sclerosis
Sami J. Barmada et al.
JOURNAL OF NEUROSCIENCE (2010)
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP43 inclusions
Vivianna M. Van Deerlin et al.
NATURE GENETICS (2010)
Common Variant in GRN Is a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly
Dennis W. Dickson et al.
NEURODEGENERATIVE DISEASES (2010)
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease
David A. Wolk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
Takashi Kasai et al.
ACTA NEUROPATHOLOGICA (2009)
TDP-43 is recruited to stress granules in conditions of oxidative insult
Claudia Colombrita et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Pallidonigral TDP-43 pathology in Perry syndrome
Christian Wider et al.
PARKINSONISM & RELATED DISORDERS (2009)
TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration
Penelope Foulds et al.
ACTA NEUROPATHOLOGICA (2008)
TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Petra Steinacker et al.
ARCHIVES OF NEUROLOGY (2008)
The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia
Ian R. A. Mackenzie et al.
CURRENT OPINION IN NEUROLOGY (2008)
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Hanae Nakashima-Yasuda et al.
ACTA NEUROPATHOLOGICA (2007)
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Catalina Amador-Ortiz et al.
ANNALS OF NEUROLOGY (2007)
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Tetsuaki Arai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)